Update
$Tempest Therapeutics (TPST.US)$ Reuters· 1 min ago
Tempest Therapeutics Inc: Overall Survival, Strongest Result From Phase 2 Trial, Will Be Primary Study Endpoint
Tempest Therapeutics Inc: Overall Survival, Strongest Result From Phase 2 Trial, Will Be Primary Study Endpoint
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
